Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin on Food Intake in Obese Adolescents
NCT03497988Phase 2Withdrawn
- Start
- Sep 2018
- Primary completion
- Jun 2020
- Modality
- Peptides
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in obesity (2 arms). Primary endpoint: Effect on Food Intake at 28 Days. Planned start Sep 2018; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03497988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497988.